Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.

Literature DB >> 1721274

Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.

A B Jain¹, R Venkataramanan, J Fung, G Burckart, J Emeigh, W Diven, V Warty, K Abu-Elmagd, S Todo, M Alessiani.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Cyclosporine
Tacrolimus

Year: 1991 PMID： 1721274 PMCID： PMC3071523

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

8 in total

1. The effect of FK 506 and CyA on the Lewis rat renal ischemia model.

Authors: M A Nalesnik; H S Lai; N Murase; S Todo; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

2. The effects of FK 506 on renal function after liver transplantation.

Authors: J McCauley; J Fung; A Jain; S Todo; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

3. FK 506 inhibition of cyclosporine metabolism by human liver microsomes.

Authors: G Omar; I A Shah; A W Thomson; P H Whiting; M D Burke
Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066

4. Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

Authors: S Todo; A J Demetris; Y Ueda; O Imventarza; K Okuda; A Casavilla; S Cemaj; A Ghalab; V Mazzaferro; B S Rhoe
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

5. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

Authors: A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

6. Is elimination of cyclosporine in bile dependent on liver graft function and biliary drainage?

Authors: A B Jain; E Elias; B K Gunson; J A Buckels; B McDowell; A Hillis; P McMaster
Journal: Transplant Proc Date: 1988-04 Impact factor: 1.066

Review 7. Clinical pharmacokinetics of cyclosporin.

Authors: R J Ptachcinski; R Venkataramanan; G J Burckart
Journal: Clin Pharmacokinet Date: 1986 Mar-Apr Impact factor: 6.447

Review 8. Clinical pharmacokinetics in organ transplant patients.

Authors: R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal: Clin Pharmacokinet Date: 1989-03 Impact factor: 6.447

8 in total

5 in total

Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.

1. The effect of FK 506 and CyA on the Lewis rat renal ischemia model.

2. The effects of FK 506 on renal function after liver transplantation.

3. FK 506 inhibition of cyclosporine metabolism by human liver microsomes.

4. Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

5. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

6. Is elimination of cyclosporine in bile dependent on liver graft function and biliary drainage?

Review 7. Clinical pharmacokinetics of cyclosporin.

Review 8. Clinical pharmacokinetics in organ transplant patients.

Review 1. Clinically significant drug interactions with cyclosporin. An update.

Review 2. Clinically significant drug interactions with new immunosuppressive agents.

Review 3. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Review 4. Clinical pharmacokinetics of tacrolimus.

Review 5. Mechanisms of clinically relevant drug interactions associated with tacrolimus.